1. Home
  2. PHD vs EDAP Comparison

PHD vs EDAP Comparison

Compare PHD & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHD
  • EDAP
  • Stock Information
  • Founded
  • PHD 2004
  • EDAP 1979
  • Country
  • PHD United States
  • EDAP France
  • Employees
  • PHD N/A
  • EDAP N/A
  • Industry
  • PHD Investment Managers
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PHD Finance
  • EDAP Health Care
  • Exchange
  • PHD Nasdaq
  • EDAP Nasdaq
  • Market Cap
  • PHD 122.0M
  • EDAP 113.2M
  • IPO Year
  • PHD N/A
  • EDAP 1997
  • Fundamental
  • Price
  • PHD $9.87
  • EDAP $2.64
  • Analyst Decision
  • PHD
  • EDAP Strong Buy
  • Analyst Count
  • PHD 0
  • EDAP 2
  • Target Price
  • PHD N/A
  • EDAP $14.00
  • AVG Volume (30 Days)
  • PHD 67.7K
  • EDAP 57.1K
  • Earning Date
  • PHD 01-01-0001
  • EDAP 11-07-2024
  • Dividend Yield
  • PHD 11.43%
  • EDAP N/A
  • EPS Growth
  • PHD N/A
  • EDAP N/A
  • EPS
  • PHD 1.27
  • EDAP N/A
  • Revenue
  • PHD N/A
  • EDAP $66,481,303.00
  • Revenue This Year
  • PHD N/A
  • EDAP $9.53
  • Revenue Next Year
  • PHD N/A
  • EDAP $15.87
  • P/E Ratio
  • PHD $7.60
  • EDAP N/A
  • Revenue Growth
  • PHD N/A
  • EDAP 8.79
  • 52 Week Low
  • PHD $8.30
  • EDAP $2.45
  • 52 Week High
  • PHD $9.81
  • EDAP $8.50
  • Technical
  • Relative Strength Index (RSI)
  • PHD 48.43
  • EDAP 31.09
  • Support Level
  • PHD $9.82
  • EDAP $2.45
  • Resistance Level
  • PHD $9.94
  • EDAP $2.74
  • Average True Range (ATR)
  • PHD 0.06
  • EDAP 0.19
  • MACD
  • PHD -0.01
  • EDAP 0.00
  • Stochastic Oscillator
  • PHD 24.95
  • EDAP 24.05

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: